Sbi Securities Co., Ltd. Amneal Pharmaceuticals, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 38 shares of AMRX stock, worth $389. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38
Previous 38
-0.0%
Holding current value
$389
Previous $318,000
3.46%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
146MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$180 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$126 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$120 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$116 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$57.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.55B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...